Integra LifeSciences Holdings Corporation (IART)

29,14 +0,39 (+1,36 %) À la clôture : 04:00PM EDT

Integra LifeSciences Holdings Corporation

1100 Campus Road
Princeton, NJ 08540
United States
609 275 0500
https://www.integralife.com

Secteur(s): Healthcare
Secteur d’activité: Medical Devices
Employés à temps plein: 3 946

Dirigeants clés

Nom	Titre	Payer	Exercé	Année de naissance
Dr. Stuart M. Essig Ph.D.	Executive Chairman	152,5k	S.O.	1962
Mr. Jan De Witte	President, CEO & Director	888,67k	S.O.	1964
Ms. Lea Daniels Knight	Executive VP & CFO	673,15k	S.O.	1972
Mr. Jeffrey A. Mosebrook	Senior VP of Finance & Principal Accounting Officer	493,14k	S.O.	1976
Mr. Eric Ian Schwartz	Executive VP, Chief Legal Officer & Secretary	549,52k	S.O.	1969
Mr. Robert T. Davis Jr.	Executive VP & President of Tissue Technologies	529,05k	44,39k	1959
Mr. Michael J. McBreen	Executive VP & President of Codman Specialty Surgical	611,28k	S.O.	1967
Mr. Stephen Leonard	Corporate VP of Global Operations & Supply Chain	S.O.	S.O.	1962
Laurene Isip	Vice President of Global Corporate Communications & Public Relations	S.O.	S.O.	S.O.
Ms. Ruth L. Fleming	Vice President of Global Marketing	S.O.	S.O.	S.O.

Les montants ont été établis en date du 31 décembre 2023 et les valeurs de compensation concernent le dernier exercice fiscal clos à cette date. Le terme « rémunération » désigne le salaire, les bonus, etc. Le terme « exercé » est utilisé pour la valeur des options exercées au cours de l’exercice fiscal. Devise exprimée en USD.

Description

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

Gouvernance d’entreprise

L’ISS Governance QualityScore de Integra LifeSciences Holdings Corporation en date du 1 juin 2024 est 1. Les scores principaux sont Audit : 1; Société : 4; Droits des actionnaires : 1; Compensation : 3.

Résultats de gouvernance d’entreprise offerts par Institutional Shareholder Services (ISS). Les résultats indiquent un rang décile par rapport à l’indice ou à la région. Un résultat décile de 1 indique un risque de gouvernance faible, tandis que 10 indique un risque de gouvernance élevé.